Discovery by Editing; cost-effective and time-efficient approach.
Metrexterol ( US 11,129,899 B1 ) A novel skin permeable Methotrexate for Psoriasis.
Estrorubicin ( US 10,576,092 B1 ) A non-cardiotoxic Doxorubicin targeting estrogen receptor.
Drug Editing & Discovery